JNJ
Johnson & Johnson
$285.75+2.23 (+0.79%)Close Nov 13, 2026
Insider trading
12 months to Sep 10, 2026- Net sold
- $155M
- Sales less buys
- Bought
- $258K
- John G. Morikis
- Sold
- $155M
- 10 insiders
- Latest buy
- Nov 26, 2025
- John G. Morikis
Buys and sales on the price
Since 2003By period
Open-market trades| Trades | 3 months | 12 months | Since 2003 |
|---|---|---|---|
| Buys | 0 | 1 | 27 |
| Sales | 7 | 17 | 206 |
| Plan sales | 0 | 0 | 0 |
| Shares bought | 00 | 1,2501.25K | 44,79344.8K |
| Shares sold | 269,340269K | 630,943631K | 7,822,0437.82M |
| Net shares | −269,340−269K | −629,693−630K | −7,777,250−7.78M |
| Net value | −$70.2M | −$155M | −$827M |
Insiders
| Insider | 12 months | Shares held |
|---|---|---|
Joaquin Duato CEO and Chairman of the Board, Director | −66.6% | 307,837 |
Jennifer L. Taubert EVP, WWC. Innovative Medicine | −8.4% | 194,451 |
Kathryn E. Wengel EVP, Chief TO and Risk Officer | −10.6% | 114,659 |
Joseph J. Wolk Exec VP, CFO | −105.5% | 85,008 as of Feb 18, 2026 |
Timothy Schmid EVP, WW Chair, MedTech | −363.2% | 26,251 |
Trades
233 trades since 2003| Type | Insider | Role | Shares | Price | Held after | |||
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sale | Timothy SchmidEVP, WW Chair, MedTech EVP, WW Chair, MedTech | EVP, WW Chair, MedTech | 33,597 at $274.74 | $274.74 | $9.23M | −56.1% Changed by trades not shown: 26.3K after | Changed by trades not shown: 26,251 |
| Aug 17, 2026 | Sale | Jennifer L. TaubertEVP, WWC. Innovative Medicine EVP, WWC. Innovative Medicine | EVP, WWC. Innovative Medicine | 15,000 at $263.36 | $263.36 | $3.95M | −7.2% 194K after | 194,451 |
| Aug 13, 2026 | Sale | Joaquin DuatoCEO and Chairman of the Board, Director CEO and Chairman of the Board, Director | CEO and Chairman of the Board, Director | 123,291 at $261.17 | $261.17 | $32.2M | −28.6% Changed by trades not shown: 308K after | Changed by trades not shown: 307,837 |
| Aug 6, 2026 | Sale | Elizabeth ForminardEVP, Chief Legal Officer EVP, Chief Legal Officer | EVP, Chief Legal Officer | 15,918 at $257.00 | $257.00 | $4.09M | −48.4% 17.0K after | 16,994 |
| Aug 5, 2026 | Sale | Joaquin DuatoCEO and Chairman of the Board, Director CEO and Chairman of the Board, Director | CEO and Chairman of the Board, Director | 48,480 at $258.15 | $258.15 | $12.5M | −13.6% 308K after | 307,837 |
| Jul 20, 2026 | Sale | Vanessa BroadhurstEVP, Global Corp Affairs EVP, Global Corp Affairs | EVP, Global Corp Affairs | 23,054 at $251.27 | $251.27 | $5.79M | −50.1% 23.0K after | 23,003 |
| Jun 11, 2026 | Sale | Kathryn E. WengelEVP, Chief TO and Risk Officer EVP, Chief TO and Risk Officer | EVP, Chief TO and Risk Officer | 10,000 at $241.15 | $241.15 | $2.41M | −8.0% 115K after | 114,659 |
| Feb 27, 2026 | Sale | Robert J. DeckerVP Corporate Controller VP Corporate Controller | VP Corporate Controller | 4,075 at $247.87 | $247.87 | $1.01M | −14.3% 24.5K after | 24,462 |
| Feb 20, 2026 | Sale | Timothy SchmidEVP, WW Chair, MedTech EVP, WW Chair, MedTech | EVP, WW Chair, MedTech | 1,322 at $245.66 | $245.66 | $325K | −4.8% 26.2K after | 26,238 |
| Feb 18, 2026 | Sale | Timothy SchmidEVP, WW Chair, MedTech EVP, WW Chair, MedTech | EVP, WW Chair, MedTech | 22,623 at $244.33 | $244.33 | $5.53M | −45.1% 27.6K after | 27,560 |
- Timothy Schmid$9.23MSep 2, 2026 · Sale33,597 at $274.74EVP, WW Chair, MedTech−56.1% of holdings, Changed by trades not shown: 26.3K after
- Jennifer L. Taubert$3.95MAug 17, 2026 · Sale15,000 at $263.36EVP, WWC. Innovative Medicine−7.2% of holdings, 194K after
- Joaquin Duato$32.2MAug 13, 2026 · Sale123,291 at $261.17CEO and Chairman of the Board, Director−28.6% of holdings, Changed by trades not shown: 308K after
- Elizabeth Forminard$4.09MAug 6, 2026 · Sale15,918 at $257.00EVP, Chief Legal Officer−48.4% of holdings, 17.0K after
- Joaquin Duato$12.5MAug 5, 2026 · Sale48,480 at $258.15CEO and Chairman of the Board, Director−13.6% of holdings, 308K after
- Vanessa Broadhurst$5.79MJul 20, 2026 · Sale23,054 at $251.27EVP, Global Corp Affairs−50.1% of holdings, 23.0K after
- Kathryn E. Wengel$2.41MJun 11, 2026 · Sale10,000 at $241.15EVP, Chief TO and Risk Officer−8.0% of holdings, 115K after
- Robert J. Decker$1.01MFeb 27, 2026 · Sale4,075 at $247.87VP Corporate Controller−14.3% of holdings, 24.5K after
- Timothy Schmid$325KFeb 20, 2026 · Sale1,322 at $245.66EVP, WW Chair, MedTech−4.8% of holdings, 26.2K after
- Timothy Schmid$5.53MFeb 18, 2026 · Sale22,623 at $244.33EVP, WW Chair, MedTech−45.1% of holdings, 27.6K after